1-3 of 3
Michael Herold, MDPhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

No Increased Risk of Secondary Neoplasms in Patients Treated with Rituximab for Non-Hodgkin’s Lymphoma : A Meta-Analysis of 9 Trials

Isabelle Fleury, MD, Sylvie Chevret, MD PhD, Michael Pfreundschuh, Gilles Salles, MDPhD, Bertrand Coiffier, MD PhD, Marinus H.J. van Oers, Christian Gisselbrecht, MDPhD, Emanuele Zucca, MD, Michael Herold, MDPhD, Michele Ghielmini, MD, Catherine Thieblemont, MDPhD
Journal: Blood
Blood (2014) 124 (21): 1659.
https://doi.org/10.1182/blood.V124.21.1659.1659
Published: 2014
Journal Articles

Long Term Follow up of the AML97-Study for Patients with AML Older Than 60 Years: A Study of the East German Hematology and Oncology Study Group (OSHO)

Christoph Kahl, MD, Rainer Krahl, PhD, Haifa Kathrin Al-Ali, MD, Herbert G. Sayer, MD PhD, Antje Schulze, MD, Michael Herold, MDPhD, Mathias Hänel, MD, Sebastian Scholl, MD, Andreas Hochhaus, MD, Lutz Uharek, MD, Georg Maschmeyer, MD, Detlev Hähling, MD, Christian Junghanss, MD, Norma Peter, Dietrich Kämpfe, MD, Erika Kettner, MD, Thomas Heinicke, MD, Thomas Fischer, MD, Ute Kreibich, MD, Hans-Heinrich Wolf, MD, Dietger Niederwieser, MD
Journal: Blood
Blood (2014) 124 (21): 3664.
https://doi.org/10.1182/blood.V124.21.3664.3664
Published: 2014
Journal Articles

BRAF Inhibition in Hairy Cell Leukemia: Multicentre Experience of 21 Patients Treated with Vemurafenib

Dietrich Sascha, MD, Andreas Pircher, MD, Mindaugas Andrulis, MD, Elena Ellert, MD, Frédéric Peyrade, Clemens-Martin Wendtner, MD, George A Follows, Martin JS Dyer, Thomas Elter, MD, Robert Zeiser, Anita Gaehler, MD, Michael Herrmann, Michael Herold, MDPhD, Claire Dearden, MD, Hanno Glimm, MD, Michael Hallek, MD, Anthony D Ho, MD, Michael Steurer, Thorsten Zenz, MD
Journal: Blood
Blood (2014) 124 (21): 3634.
https://doi.org/10.1182/blood.V124.21.3634.3634
Published: 2014